Our mission is better health care outcomes.

Similar documents
Our mission is better health care outcomes.

Our mission is better health care outcomes.

2019 Catalog Hospital and Ophthalmology Products and Services

OUR MISSION IS TO BECOME A LEADING MEMBER OF THE GLOBAL SPECIALTY GENERIC INDUSTRY BY 2020.

WELCOME. To learn more or place an order, please call

RE: Temporary Changes to Aggregate Production Quotas for IV Opioid Products to Address Shortages

Help Prevent Medication Errors with PDC Healthcare s Anesthesia Labels & Tapes

BT item # Description Mfctr ETA for next release Date Mfctr expects back orders to clear Possible sub ** Description. mfctr allocation.

BT item # Description Mfctr ETA for next release Date Mfctr expects back orders to clear Possible sub ** Description. mfctr allocation.

Active Pharmaceutical Ingredient (API) List List Updated March 1st, 2019

Customer Service: Shop online at

Don't forget to see our PharmaTags: Sterile Medication Labels at

Hazardous Materials Medication Box and Exchange Procedure

Hazardous Materials Medication Box and Exchange Procedure

SOUTHEAST MICHIGAN MEDICATION EXCHANGE AND REPLACEMENT PROCEDURE

Section 8.4 Special Dilutions

May 4, RE: Controlled Substances Quotas [Docket No. DEA-480]

Drug Max dose approved for IVP Dilution Rate Monitoring Parameters. Dilution not necessary (Available in prefilled syringe)

Enforcement Report - Week of August 15, 2018

OFFERâ S INJECTABLES

NOTICES DEPARTMENT OF HEALTH

SREMS Minimum Equipment Standards

UTMB DEPARTMENT OF PHARMACY POLICY AND PROCEDURES Section Medication Use ADMINISTRATION OF MEDICATION BY IV PUSH

Enforcement Report - Week of November 1, 2017

URGENT: Important Safety Information

The following equipment and supplies shall be maintained at a minimum. Agencies should consider typical or expected usage for optimal inventory

Supply should only occur if requesting signature is on approved list held by the issuing pharmacy

Pharmacy Shortages January 15, 2014 (Updated monthly, if not more often)

247 CMR BOARD OF REGISTRATION IN PHARMACY

Average of qty_parlvl rx_disp BIE_OR BIE_ORCOR2 BIE_PACU BIS_OR BIS_PACU BIW_OR BIW_ORCOR2 BIW_PACU Grand Total AA Open Fridge AA Used

040716_ANDI_VENTIS WEBSITE(new) Printout 1. HOME PAGE. Welcome to our world of Dry Powder Inhalers!

2

Pharmaceutical Shortage Update

AuroMedics Corporate Brochure

ANESTHESIA DRUG REVIEW

DRUG SCHEDULES REGULATION CHANGES JUNE 2018

Active Pharmaceutical Ingredient (API) List List Updated 03/08/2018

Table A1: Fifty Most Often Repeated Oral Drug Product Shortages (35 ingredients), Canada,

Original Date of issue: 01/11/2005 Last Reviewed: 01/05/2011 Version:4 Page 1 of 7

Pharmacy Instructions for Preparation

J1556 INJECTION, IMMUNE GLOBULIN (BIVIGAM) 500 MG $ J1559 INJECTION, IMMUNE GLOBULIN (HIZENTRA) 100 MG $14.364

EFFECTIVE DATE: 01/2007 REVISED: 07/2008, 6/11, 3/12, 8/12, 1/15. Purpose:

Enforcement Report - Week of May 2, 2018

THE COMPLEX JOURNEY OF A VACCINE PART I The manufacturing chain, regulatory requirements and vaccine availability

Sample. Affix patient label within this box.

6/7/2017 CHANGES IN PHARMA REGULATIONS HOW IT AFFECTS THE OR NURSE DISCLOSURE OBJECTIVES

Physician Orders PEDIATRIC: LEB Critical Care Respiratory Plan

(1) 10mL 0.5% (2) 1mL 40mg. (1) 10mL 1% (2) 2mL 2% (1) 2mL 2% (1) 2mL 1%

Medications and IV Fluids List

Class I Drugs Event Event ID: Product Type: Status: Date Terminated: Recall Initiation Date: Voluntary / Mandated: Center Classification Date:

Compounding Medication Regulations

Boehringer Ingelheim BioXcellence. Producing Value. Global Contract Manufacturing Excellence

Disclosure. Objectives. Objectives. Introduction. Introduction. Non-Sterile Compounding/Calculations

UPLB-S , SUPPLY AND DELIVERY OF DRUGS AND MEDICINES TECHNICAL SPECIFICATION FOR THE PUBLIC BIDDING OF: OPENING OF BIDS:

DME MAC Jurisdiction B Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2019 through 03/31/2019

DME MAC Jurisdiction C Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2018 through 03/31/2018

Administration and Supply of Emergency Medicines

2

Martindale Pharma is a UK pharmaceutical manufacturing company supplying niche products to over 50 countries worldwide.

INPATIENT INTERVENTIONAL RADIOLOGY PLAN - Phase: Pre-Procedure Orders

Measure Abbreviation: PONV 01 (MIPS 430)

UP Health System Marquette Medication Guideline High Alert Drugs

Pharmacology Drug Dosage Calculations

DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Apini$r$iy -tq 5-f

Measure Abbreviation: PONV 01 (MIPS 430)

IMDG CODE Poison Treatment Chest

EMS PROTOCOLS AND PROCEDURES MANUAL

HARD TWO-PIECE HPMC CAPSULES FOR PHARMACEUTICAL APPLICATIONS IN INHALATION

Adult Care Plan Allergies: Date / / OR. Anesthesia Technique. Airway Mal / SMS FB / TMJ / CS / Teeth. Induction Agents

If you have any questions, please contact Jerry Webb at ext or

MANUFACTURER OF HIGH PURITY SPECIALTY CHEMICALS

1. The Director or Nursing or Designee shall conduct a check of equipment and materials necessary to conduct the execution.

San Juan Islands EMS Meeting October 1, :00pm 1:00pm Zoom:

720 cases. 20 states. Conflict of Interest Declaration. New England Compounding Center (NECC) timeline. (NECC) timeline (continued) 3/28/2013

Approximate Cost for Patients

Sierra Sacramento Valley EMS Agency Program Policy. ALS Specialty Program Provider Inventory Requirements

North Carolina College of Emergency Physicians Standards for EMS Medications and Skills Use

Maximizing Sustainability Through Reprocessing Single Use Devices

RMF South Sudan Receives Donation of Essential Drugs and Medical Supplies from Direct Relief

Injection Dosage Calculations

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

IMDG CODE Poison Treatment Chest

Pr Pascal BONNABRY Head of pharmacy

South Plains Emergency Medical Services, Inc. P.O. Box Lubbock, Texas 79453

Release of the 2017/18 Invitation to Tender

Satisfactory Analgesia Minimal Emesis in Day Surgeries. (SAME-Day study) A Randomized Control Trial Comparing Morphine and Hydromorphone

CDER Compliance Update

Atropine Sulfate Injection

The Science of Palatability

Re: FDA-2015-N-0030; Comments to the Public Docket on Compounding of Human Drug Products under the Federal Food, Drug, and Cosmetic Act

Hospira Issues A Voluntary Nationwide Recall For 8.4% Sodium Bicarbonate Injection, USP,

Leader in custom manufacturing. for the pharmaceutical and nutraceutical industries.

Intranasal Administration of Naloxone by the EMT-Basic FDNY Proposal for a New York State Demonstration Project

URGENT: Important Safety Information

HIGH ALERT MEDICATIONS

South Dakota State Board of Dentistry PO Box 1079, 1351 N. Harrison Ave. Pierre, SD Ph: Fax:

FROM GAMETES TO BLASTOCYSTS. Simpler Processes, Less Stress, Better Results.

The Science of Palatability

A New Revolution of Relief

Transcription:

Our mission is better health care outcomes. Purity Product Catalog December 2018 nephronpharm.com 1 (844) 224-2225

Nephron Pharmaceuticals Corporation is a leading manufacturer of generic respiratory and 503B outsourcing products. We produce of Racemic Epinephrine Inhalation Solution, 2.25%, 0.5mL. Nephron has over 20 years of sterile pharmaceutical manufacturing experience. Our cgmp compliant, 503B Outsourcing facility uses industry-leading technology to deliver sterile, high quality pharmaceutical products. 503B Outsourcing with cgmp Quality needs. Nephron has responded to the drug shortage with 24-7 production, free UPS overnight shipping and investments in industry-leading technology to deliver sterile, high quality pharmaceutical products. Nephron Pharmaceuticals Corporation We are an industry leading manufacturer of sterile, preservative-free respiratory inhalation medications. Our customers include hospitals, retail pharmacies, home care companies, long term care facilities, and mail order pharmacies. Our medications are available individually wrapped and barcoded for ease of use during bedside scanning. All Nephron products are proudly made in the USA! Multimodal Opioid Free Antiemetic Infiltrative Analgesic outcomes. Call 1 (844)224-2225 to learn more MicroVapor Devices produced by MicroVapor Devices, a sister company to Nephron Pharmaceuticals. Learn more at MicroVaporDevices.com Page 2 of 8

Efficiency Purity Efficacy Dedicated Professionals The Nephron team is dedicated to exceeding quality, regulatory, and validation standards. All products are produced on fully validated equipment and are verified with advanced in-house analytical, chemistry, and microbiological testing. Nephron stands by its commitment to distribute only the highest quality medication, after all test results meet specification. It is our mission to deliver safe, quality products day in and day out. We are licensed in all 50 states and regularly inspected by the FDA. Dependable Service & Technology Nephron 503B Outsourcing Facility is located within our industry leading manufacturing campus, so we can use our quality, regulatory, and validation resources for sterile drug compounding. Our outsourcing division is regularly inspected by the FDA and operates certified clean rooms using current Good Manufacturing practices (cgmp). We have invested in the latest technology advancements, so you can be confident in our process, service, logistics, and uninterrupted supply chain. We are positioned to help your health care facility succeed. Quality Assurance Our team of experts ensure every substance that enters and exits our facility is safe for use. When active pharmaceutical ingredients arrive on site, our quality assurance department samples and reviews the ingredients before they are released for use. We perform additional quality checks before, during and after we formulate product and review samples from each batch within our in-house chemistry and micro-biology laboratories. Contact us at 1 (844) 224-2225 Page 3 of 8

503B Products NDC Product Description All items are available for KitCheck upon request. Fill Volume BUD Units/carton Cartons/case Units/case Drug Shortage/ Medically Necessary 69374-988-10 Amino Acid Injection, 50g/1000mL (50mg/mL) 25g L-Arginine HCI: 25g L-Lysine HCI 1000mL 90 Days 2 1 2 N 69374-935-03 Atropine Sulfate For Injection, USP 1.2 mg/3 ml (0.4 mg/ml) -Preservative Free 3mL 180 Days 5 6 30 N 69374-993-30 Bupivacaine 0.25% HCI Injection, USP-Preservative Free 30mL 120 Days 5 6 30 N 69374-994-02 Bupivacaine HCI 0.75% in Dextrose 8.25% Injection, USP 2mL 2mL 90 Days 5 6 30 N 69374-970-50 0.125% Bupivacaine HCl Injection, USP 62.5 mg/50 ml (1.25mg/mL) 50mL 120 Days 5 6 30 N 69374-913-10 10% Calcium Chloride Injection, USP - 1.4 meq Ca++/mL 1 g/10ml (100 mg/ml) 10mL 180 Days 5 6 30 N 69374-950-10 10% Calcium Gluconate Injection, USP; 0.465 meq Ca++/mL 1000 mg/10 ml (100 mg/ml) 10mL 180 Days 5 6 30 N 69374-984-10 Del Nido Cardioplegia 1000mL 1000mL 45 Days 1 4 4 N 69374-953-50 50% Dextrose Injection, USP 25 g/50 ml (0.5 g/ml) 50mL 90 Days 5 6 30 N 69374-965-02 diazepam Injection USP 10 mg/2 ml (5 mg/ml) 2mL 120 Days 5 6 30 N 69374-989-05 Diltiazem Hydrochloride, USP 25mg/5mL (5mg/mL) 5mL 90 Days 5 6 30 N 69374-901-05 ephedrine Sulfate Injection, USP 25 mg/5 ml (5 mg/ml) 5mL 180 Days 5 6 30 N 69374-925-10 EPINEphrine Injection, USP 1 mg/10 ml (0.1 mg/ml) 10mL 120 Days 5 6 30 N 69374-978-02 Fentanyl Citrate Injection, USP 100 mcg/2 ml (50 mcg/ml) 2mL 120 Days 5 6 30 N 69374-996-05 Fentanyl Citrate Injection, USP 50mcg/5mL (10mcg/mL) 5mL 90 Days 5 6 30 N Page 4 of 8

503B Products NDC Product Description All items are available for KitCheck upon request. Fill Volume BUD Units/carton Cartons/case Units/case Drug Shortage/ Medically Necessary 69374-903-03 GLYCOpyrrolate For Injection, USP 0.6 mg/3 ml (0.2 mg/ml) - Preservative Free 3mL 180 Days 5 6 30 N 69374-903-05 GLYCOpyrrolate Injection, USP 1 mg/5 ml (0.2 mg/ml) -Preservative Free 5mL 180 Days 5 6 30 N 69374-983-01 HYDROmorphone HCl Injection, USP 1 mg/1 ml (1 mg/ml) 1mL 90 Days 5 6 30 N 69374-982-10 Ketamine Hydrochloride Injection, USP 100 mg/10 ml (10mg/mL) 10mL 120 Days 5 6 30 N 69374-982-33 Ketamine Hydrochloride Injection, USP 30 mg/3 ml (10mg/mL) 3mL 180 Days 5 6 30 N 69374-982-55 Ketamine Hydrochloride Injection, USP 50 mg/5 ml (10 mg/ml) 5mL 180 Days 5 6 30 N 69374-946-04 LABETalol HCl Injection, USP 20 mg/4 ml (5 mg/ml) -Preservative Free 4mL 180 Days 5 6 30 N 69374-949-05 Lidocaine HCl For Injection, USP 2% 100 mg/5 ml (20 mg/ml) -Preservative Free 5mL 120 Days 5 6 30 N 69374-985-05 Lidocaine HCl Injection, USP 1% 50 mg/5 ml (10 mg/ml) -Preservative Free 5mL 120 Days 5 6 30 N 69374-979-02 Morphine Sulfate Injection, USP 2 mg/2 ml (1 mg/ml) -Preservative Free 2mL 120 Days 5 6 30 N 69374-922-03 NEOstigmine Methylsulfate For Injection, USP 2 mg/2 ml (1 mg/ml) - Preservative Free 2mL 180 Days 5 6 30 N 69374-932-03 NEOstigmine Methylsulfate For Injection, USP 3 mg/3 ml (1 mg/ml) - Preservative Free 3mL 180 Days 5 6 30 N 69374-942-04 NEOstigmine Methylsulfate Injection, USP 4 mg/4 ml (1 mg/ml) - Preservative Free 4mL 180 Days 5 6 30 N 69374-902-05 NEOstigmine Methylsulfate Injection, USP 5 mg/5 ml (1 mg/ml) _ Preservative Free 5mL 180 Days 5 6 30 N 69374-986-02 Ondansetron Injection, USP 4 mg/2 ml (2 mg/ml) 2mL 120 Days 5 6 30 N 69374-958-05 Potassium Chloride (KCl) Injection Concentrate, USP 10 meq/5ml (2 meq/ml) 5mL 180 Days 5 6 30 N Page 5 of 8

503B Products NDC Product Description All items are available for KitCheck upon request. Fill Volume BUD Units/carton Cartons/case Units/case Medically Necessary 69374-976-21 Potassium Chloride Injection, 14.9 mg/ ml (20 meq/ 100 ml) 100mL 120 Days 64 1 64 N 69374-955-10 PHENYLephrine HCl Injection, USP 0.4 mg/10 ml (40 mcg/ml) 10mL 180 Days 5 6 30 N 69374-956-10 PHENYLephrine HCl Injection, USP 0.8 mg/10 ml (80 mcg/ml) 10mL 180 Days 5 6 30 N 69374-957-10 PHENYLephrine HCl Injection, USP 1 mg/10 ml (100 mcg/ml) 10mL 180 Days 5 6 30 N 69374-924-05 ROCURonium Bromide For Injection, 50 mg/5 ml (10 mg/ml) -Preservative Free 5mL 120 Days 5 6 30 N 69374-924-05 ROCURonium Bromide Injection, 75 mg/7.5ml (10mg/mL) -Preservative Free 7.5 ml 90 days 5 6 30 N 69374-987-10 0.2% Ropivacaine HCl Injection, USP 200mg/100mL (2mg/mL) 100mL 90 Days 64 1 64 N 69374-914-50 8.4% Sodium Bicarbonate Injection, USP 4.2 g/50 ml (1mEq/mL) 50mL 90 Days 5 6 30 N 69374-906-05 Sodium Citrate Solution, USP 4% 200 mg/5 ml 10 ml 120 Days 5 6 30 N 69374-968-25 Sodium Chloride USP, 0.9% 2.25 g/ 250 ml 250mL 120 Days 35 1 35 N 69374-967-50 Sodium Chloride, USP 0.9% (450 mg/50 ml) 50mL 120 Days 64 1 64 N 69374-968-10 Sodium Chloride, USP 0.9% (900 mg/100 ml) 100mL 120 Days 64 1 64 N 69374-980-05 Sterile Water For Injection, USP 5 ml 5mL 365 Days 30 30 900 N 69374-920-05 SUCCINYLcholine Chloride For Injection, USP 100 mg/5 ml (20mg/mL) Preservative Free 5mL 90 Days 5 6 30 N 69374-919-10 SUCCINYLcholine Chloride For Injection, USP 200 mg/10 ml (20 mg/ml) Preservative Free 10mL 90 Days 5 6 30 N 69374-910-04 Trisodium Citrate 0.5% (0.5%/4 L) 4000mL 180 Days 2 1 2 N Page 6 of 8

Inhalation Singles NDC Product Description (All inhalations are individually wrapped and barcoded) Fill Volume BUD Units/carton Cartons/case Units/case 0487-0301-01 Albuterol Sulfate Inhalation Solution 0.021%, Singles 30 Count 3mL 18 Months 30 12 360 0487-9904-25 Albuterol Sulfate Inhalation Solution 0.042%, Singles 25 Count 3mL 18 Months 25 12 300 0487-9904-01 Albuterol Sulfate Inhalation Solution 0.042%, Singles 30 Count 3mL 18 Months 30 12 360 0487-9501-01 Albuterol Sulfate Inhalation Solution 0.083%, Singles 30 Count 3mL 24 Months 30 12 360 0487-9901-30 Albuterol Sulfate Inhalation Solution 0.5%, Singles 30 Count 0.5mL 18 Months 30 12 360 0487-9601-01 Budesonide Inhalation Suspension 0.25mg/2mL For Inhalation, Singles 30 Count 2mL 24 Months 30 12 360 0487-9701-01 Budesonide Inhalation Suspension 0.5mg/2mL For Inhalation, Singles 30 Count 2mL 24 Months 30 12 360 0487-0201-01 Ipratropium Bromide 0.5mg & Albuterol Sulfate 3mg Inhalation Solution, Singles 30 Count 3mL 24 Months 30 12 360 0487-9801-01 Ipratropium Bromide Inhalation Solution 0.02%, Singles 30 Count 2.5mL 24 Months 30 12 360 0487-5901-99 S-2 Racepinephrine Inhalation Solution, USP 2.25%, Singles 30 Count 0.5mL 18 Months 30 12 360 0487-9003-60 Sodium Chloride Inhalation Solution, USP 3% Singles 30 Count 4mL 24 Months 30 30 900 0487-9007-60 Sodium Chloride Inhalation Solution, USP 7% Singles 30 Count 4mL 24 Months 30 30 900 0487-9302-01 Sodium Chloride Inhalation Solution, USP, 0.9% 25 Count 5mL 24 Months 25 36 900 0487-9301-33 Sodium Chloride Inhalation Solution, USP 0.9% Singles 30 Count 3mL 24 Months 30 12 360 Page 7 of 8

Opioid-Free Pain Management NDC Product Description Fill Volume BUD Units/Carton Cartons/Case Units/Case 69374-509-20 BKK, Bupivacaine 20mL, Ketorolac 20mL, Ketamine 20mL - 3 Syringe Kit (Not available for individual purchase) 69374-501-20 Bupivacaine HCI 150 mg/20ml with Epinephrine 50mcg/20mL Injection, USP 20mL 60 1 1 3 69374-999-20 Ketorolac Tromethamine Injection, USP 60mg/20mL 20mL 60 1 1 3 69374-998-20 Ketamine HCI Injection, USP 60mg/20mL 20mL 60 1 1 3 MicroVapor Devices Item Number Product Description Primary Packaging Administration Delivery System Devices percarton Carton/Case PNVM-510K-01 Pocket Neb Portable Vibrating Mesh Nebulizer DEVICE Aerosol drug delivery Multi Dose 1 4 Page 8 of 8

Nephron Pharmaceuticals Corporation is a leading manufacturer of generic respiratory and 503B outsourcing products. nephronpharm.com 1 (844) 224-2225